Medicine Man Technologies (Medicine Man Technologies) Long-Term Capital Lease Obligation : $30.7 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies Long-Term Capital Lease Obligation?

Medicine Man Technologies's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $30.7 Mil.

Medicine Man Technologies's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 ($23.5 Mil) to Dec. 2023 ($30.1 Mil) and increased from Dec. 2023 ($30.1 Mil) to Mar. 2024 ($30.7 Mil).

Medicine Man Technologies's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($8.7 Mil) to Dec. 2022 ($17.3 Mil) and increased from Dec. 2022 ($17.3 Mil) to Dec. 2023 ($30.1 Mil).

Medicine Man Technologies Long-Term Capital Lease Obligation Historical Data

The historical data trend for Medicine Man Technologies's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies Long-Term Capital Lease Obligation Chart

Medicine Man Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.07

2.65

8.72

17.31

30.13

Medicine Man Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															19.11	22.10	23.53	30.13	30.74

Medicine Man Technologies (OTCPK:SHWZ) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Medicine Man Technologies Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicine Man Technologies (Medicine Man Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SHWZ:Canada

Address

4880 Havana Street, Suite 201, Denver, CO, USA, 80239

Website

https://www.schwazze.com

Medicine Man Technologies Inc is engaged in providing general consulting services in the cannabis industry. The company also provide seminar which includes giving guidance and tips on industry opportunities, medical and recreational market trends, cultivation methodologies and technology, extraction technology, dispensary operation, security requirements. The company's operating segment includes- Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products; Other, consisting of all other income and expenses. It generates maximum revenue from the Retail segment. The company is now operating under its new trade name, Schwazze.

Executives

Christine Jones	officer: Chief Legal Officer	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster	officer: CFO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy	director, officer: President	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck	director	625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood	director	55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji	director	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart	director	C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye	director, 10 percent owner, officer: CEO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad	director, 10 percent owner	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Brian Ruden	10 percent owner	C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239